Cargando…
Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
Background: Clinical practice guidelines for the treatment of idiopathic pulmonary fibrosis (IPF) currently recommend pirfenidone and nintedanib. However, there is a lack of evidence from head-to-head comparisons. Objectives: To perform a systematic review and network meta-analysis (NMA) to access t...
Autores principales: | Skandamis, Aristeidis, Kani, Chara, Markantonis, Sophia L., Souliotis, Kyriakos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484486/ https://www.ncbi.nlm.nih.gov/pubmed/31044096 http://dx.doi.org/10.1080/21556660.2019.1597726 |
Ejemplares similares
-
Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019) -
Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis
por: Kamiya, Hiroyuki, et al.
Publicado: (2020) -
Prognostic factors for acute exacerbation of idiopathic pulmonary fibrosis: protocol for a systematic review and meta-analysis
por: Kamiya, Hiroyuki, et al.
Publicado: (2019) -
Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020) -
Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: protocol for a systematic review
por: Kamiya, Hiroyuki, et al.
Publicado: (2018)